Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 14,060

Document Document Title
WO/2012/003164
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity agamst hepatitis C virus (HCV) and may be useful in treating those infected wi...  
WO/2012/002512
A polymerisable compound having a terminal having an α-methylene-γ-butyrolactone group and a terminal having a photopolymer or a photocrosslinking group; a polymer for forming a liquid crystal aligning agent capable of aligning liquid ...  
WO/2012/002513
Disclosed is a polymerizable compound represented by formula (1). In formula (1), V represents a single bond or -R1O-, wherein R1 represents a linear or branched alkylene group having 1 to 10 carbon atoms, and W represents a single bond ...  
WO/2012/002511
The liquid crystal-aligning agent comprises polyimide precursor with side chains that vertically orient liquid crystals and photoreactive side chains that contain at least one kind selected from methacrylic, acrylic, vinyl and cinnamoyl ...  
WO/2012/002527
Provided are a novel heterocyclic compound and salt thereof applicable in the selective inhibition of the degradation of p27Kip1. The compound and the salt thereof are represented in formula (1). [In the formula: A represents an alkyl gr...  
WO/2012/001148
The present invention relates to calcium salts of compounds of the general formula (I) wherein X is selected from the group consisting of CH2, S, or O; D is O or S; R8 is hydrogen or alkyl; E is an optionally substituted phenylene group;...  
WO/2012/001151
The present invention relates to a salt selected from the group comprising the N-methyl-D- glucamine salt (NMG), the diethylamine salt (DEA) salt, the magnesium salt, the tromethamine salt, the choline salt, the L-arginine salt, the zinc...  
WO/2012/000608
The present invention relates to novel beta-aminoaldehyde derivatives of the formulae (I), (II) and (III), in which the substituents R1 to R5 and A have the meaning given in the description, to a novel process for their preparation, to i...  
WO/2012/001620
The present invention relates to a multilayer catalyst for preparing phthalic anhydride which has a plurality of catalyst layers arranged in succession in the reaction tube, with the individual catalyst layers having alkali metal content...  
WO/2012/000608
The present invention relates to novel beta-aminoaldehyde derivatives of the formulae (I), (II) and (III), in which the substituents R1 to R5 and A have the meaning given in the description, to a novel process for their preparation, to i...  
WO/2011/161945
Disclosed are a new alkoxyimino derivative or an agriculturally acceptable salt thereof and a pest control agent containing as an active ingredient the derivative or a salt thereof, wherein the agent shows an excellent controlling effect...  
WO/2011/161141
A process for separating furfural from a liquid aqueous phase comprising furfural and one or more organic acids, which process comprises a step a) extracting furfural from the liquid aqueous phase into a liquid aromatic phase comprising ...  
WO/2011/161201
A compound of formula (I). The compound is useful for treating cancer and inflammatory diseases. A pharmaceutical composition containing the compound.  
WO/2011/163610
The invention provides a compound of formula I:or a salt thereof, wherein R3-R8 and X and Y have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as an...  
WO/2011/163610
The invention provides a compound of formula I:or a salt thereof, wherein R3-R8 and X and Y have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as an...  
WO/2011/158050
This invention relates to a process for the preparation of N-[2-n-butyl-3-{4-[(3- dibutylamino)-propoxy]-benzoyl} - 1-benzofuran-5-yl]-methane-sulfonamide of formula (I) and its pharmaceutically acceptable salts, according to one of the ...  
WO/2011/159297
GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.  
WO/2011/158928
Provided is a process for efficiently producing a trimellitic anhydride phenyl ester in high yield. The process for producing a trimellitic anhydride phenyl ester comprises subjecting a carboxylic acid phenyl ester and trimellitic anhydr...  
WO/2011/159781
The present invention includes antagonists of human type 2 taste receptors (hT2Rs) having structural Formula (I). The present invention also provides compositions containing these antagonists, the use of these antagonists for modulating ...  
WO/2011/157790
The present invention provides an organic electronic device including a first electrode, a second electrode, and an organic layer interposed between the first electrode and the second electrode, wherein the organic layer comprises an org...  
WO/2011/159781
The present invention includes antagonists of human type 2 taste receptors (hT2Rs) having structural Formula (I). The present invention also provides compositions containing these antagonists, the use of these antagonists for modulating ...  
WO/2011/158178
The instant invention relates to a method of determining whether to administer to a patient dronedarone, or a pharmaceutically acceptable salt thereof, in combination with a potassium-depleting diuretic for the treatment of arrhythmia co...  
WO/2011/158249
Disclosed is a process for the preparation of milnacipran intermediate, a compound of formula ΙII, and its use in the preparation of pure milnacipran.  
WO/2011/158333
The present invention provides a method for synthesizing a zederone analogue derived from natural materials, a precursor useful in synthesis of the zederone analogue, and an intermediate useful for synthesizing the zederone precursor. Sp...  
WO/2011/156321
Provided herein are substituted furanyl compounds of formula (I), pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, p...  
WO/2011/153866
3-(o-Methylphenyl)-2-oxo-1-oxaspiro[4,5]-dec-3-en-4-ol derivatives shown as formula (I) with insecticidal, acaricidal and fungicidal activities and their preparation methods are disclosed, in which R are the following substitutes.  
WO/2011/156321
Provided herein are substituted furanyl compounds of formula (I), pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, p...  
WO/2011/156655
Compounds that bind the glucagon-like peptide 1 receptor (GLP-1) receptor are provided including compounds which are modulators of the GLP-1 receptors and compounds which are capable of inducing a stabilizing effect on the receptor for u...  
WO/2011/153923
A process for preparing dronedarone or pharmaceutically acceptable salts thereof. The process comprises reacting 5-amino-2-butyl-3-(4-[3-(dibutylamino)propoxy]benzoyl) benzofuran (compound A) with methanesulfonyl chloride without any cat...  
WO/2011/153865
Disclosed are 3-ortho-methylphenyl-2-oxo-1-oxaspiro[4,4]non-3-en-4-ol of formula (I), derivatives and preparation method thereof, wherein (II) is described as the description. The compounds of formula (I) can be used as pesticides, acari...  
WO/2011/153502
The invention provides novel compositions based on a structure designated as "Honaucin A", including Honaucin A variants and analogs, and pharmaceutical compositions, liposomes and nanoparticles comprising them, and methods of making and...  
WO/2011/151442
A new route of synthesis of the compound Aliskiren of formula (I), used in the treatment of hypertension, is described.  
WO/2011/151442
A new route of synthesis of the compound Aliskiren of formula (I), used in the treatment of hypertension, is described.  
WO/2011/151348
This invention relates to heterocyclic amino acid derivatives suitable for labeling or already labeled with 18F or 19F, methods of preparing such compounds, compositions comprising such compounds, kits comprising such compounds or compos...  
WO/2011/153502
The invention provides novel compositions based on a structure designated as "Honaucin A", including Honaucin A variants and analogs, and pharmaceutical compositions, liposomes and nanoparticles comprising them, and methods of making and...  
WO/2011/149938
Processes for the synthesis of (3aS,7aR)-hexahydroisobenzofuran-1-(3H)-one, comprising comprising enzymatic hydrolysis of dimethyl cyclohexane-1,2-dicarboxylate to form (1S,2R)-2-(methoxycarbonyl) cyclohexanecarboxylic acid. The enzyme c...  
WO/2011/148909
Disclosed is an organic electroluminescent element which comprises: a positive electrode; a negative electrode; and at least a hole transport layer, a first light emitting layer, a second light emitting layer and an electron transport la...  
WO/2011/149938
Processes for the synthesis of (3aS,7aR)-hexahydroisobenzofuran-1-(3H)-one, comprising comprising enzymatic hydrolysis of dimethyl cyclohexane-1,2-dicarboxylate to form (1S,2R)-2-(methoxycarbonyl) cyclohexanecarboxylic acid. The enzyme c...  
WO/2011/149341
The invention is directed to a process for the treatment of lignocellulosic biomass to recover one or more components or derivatives of components thereof, said process comprising treating said biomass at a temperature of at least 75°C ...  
WO/2011/145048
The present invention relates to the use of a compound of having the following formula: wherein either 1 or 2 of the dotted lines represent a double bond, in order to provide or enhance buttery, creamy, green, fatty and/or milky note to ...  
WO/2011/146182
Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein E, X, G, W2 and Z are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods...  
WO/2011/145669
Disclosed are the compound represented by formula (I) which is useful as a therapeutic or prophylactic agent for various partial and/or generalized epileptic seizures, or a salt thereof. [In the formula, ring A and ring B independently r...  
WO/2011/145022
Compounds of Formula I that inhibit microsomal triglyceride transfer protein (MTP) and/or apolipoprotein B (Apo B) secretion and their uses in the treatment of diseases linked thereto in animals are described herein.  
WO/2011/146577
Functionalized polymer matrix and/or reinforcement materials that are capable of a thermoreversible Diels-Alder reaction are useful for making composite materials. Also disclosed is a composite material which includes one or both of func...  
WO/2011/145352
A process for the preparation of optically active cyano compounds, which includes a step of reacting an α,β-unsaturated compound having a prescribed structure with a cyanating agent in the presence of a titanium-containing catalyst tha...  
WO/2011/142466
Provided is an epoxy resin composition which produces a cured product having a low melt viscosity, excellent fluidity, and also excellent flame-retarding performance, adhesiveness, and heat resistance. The epoxy resin composition compris...  
WO/2011/142009
Disclosed is a preservative for preserving wood comprising 5-methyl-2-trifluoromethylfuran-3-carboxylic acid anilide derivative represented by formula (A), wherein R represents an isopropyl group or an isopropoxy group, as an active ingr...  
WO/2011/141458
The present invention refers to compounds of formula (I), as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer, aging related di...  
WO/2011/140998
Aralkyl diamine derivatives of the following formula, pharmaceutically acceptable salts or uses thereof as antidepressant. The derivatives have triplex inhibiting activities on the reuptake of 5-HT, dopamine and noradrenalin, which can b...  
WO/2011/140334
The present invention provides various compounds, compositions, and methods. In some embodiments, provided compounds have activity as, for example, inhibitors of protein translation.  

Matches 701 - 750 out of 14,060